Bio-Techne
TECH
#2187
Rank
A$12.91 B
Marketcap
A$82.57
Share price
-1.82%
Change (1 day)
-20.17%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2025 (TTM): A$0.79

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is A$0.74. In 2024 the company made an earnings per share (EPS) of A$1.42 a decrease over its 2023 EPS that were of A$2.01.

EPS history for Bio-Techne from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$0.79-44.02%
2024A$1.42-29.58%
2023A$2.01-14.97%
2022A$2.3724.16%
2021A$1.9117.98%
2020A$1.62-10.94%
2019A$1.81101.57%
2018A$0.90-16.99%
2017A$1.0845.02%
2016A$0.75-20.97%
2015A$0.95-14.97%
2014A$1.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
A$25.19 3,317.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
A$7.90 971.15%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
A$11.65 1,480.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
A$7.19 875.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
A$2.79 278.28%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
A-$0.30-140.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
A-$34.46-4,775.00%๐Ÿ‡บ๐Ÿ‡ธ USA